(AMLX) Amylyx Pharmaceuticals - Performance 182.3% in 12m
Compare AMLX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-37.01%
#89 in Group
Rel. Strength
98.32%
#135 in Universe
Total Return 12m
182.32%
#7 in Group
Total Return 5y
-71.72%
#114 in Group
P/E -
(?) Percentile in Group
P/E Forward 2.77
6th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -61.74%
(?) Percentile in Group
12m Total Return: AMLX (182.3%) vs XLV (1.7%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
| LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
| NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
| SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
| SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
| SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: AMLX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AMLX
| Total Return (including Dividends) | AMLX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 44.35% | -3.79% | -0.87% |
| 3 Months | 40.00% | -3.99% | -7.58% |
| 12 Months | 182.32% | 1.72% | 11.88% |
| 5 Years | -71.72% | 55.40% | 110.33% |
| Trend Score (consistency of price movement) | AMLX | XLV | S&P 500 |
| 1 Month | 89.2% | -3.2% | 23% |
| 3 Months | 50.6% | -71.4% | -88.5% |
| 12 Months | 73.0% | -17.5% | 55.1% |
| 5 Years | -69.4% | 89.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #8 | 50.0% | 45.6% |
| 3 Month | #8 | 45.8% | 51.5% |
| 12 Month | #8 | 178% | 152% |
| 5 Years | #100 | -74.3% | -77.3% |
FAQs
Does AMLX Amylyx Pharmaceuticals outperforms the market?
Yes,
over the last 12 months AMLX made 182.32%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months AMLX made 40.00%, while XLV made -3.99%.
Over the last 3 months AMLX made 40.00%, while XLV made -3.99%.
Performance Comparison AMLX vs Indeces and Sectors
AMLX vs. Indices AMLX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.58% | 45.2% | -3.51% | 170% |
| US NASDAQ 100 | QQQ | -3.61% | 43.0% | -3.94% | 170% |
| US Dow Jones Industrial 30 | DIA | -1.64% | 47.5% | -3.42% | 173% |
| German DAX 40 | DAX | -1.35% | 43.0% | -23.0% | 158% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.38% | 47.2% | -0.52% | 176% |
| Hongkong Hang Seng | HSI | -1.59% | 44.3% | -5.43% | 168% |
| India NIFTY 50 | INDA | 0.26% | 40.3% | -3.80% | 179% |
| Brasil Bovespa | EWZ | -1.78% | 39.8% | -7.21% | 188% |
AMLX vs. Sectors AMLX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.83% | 45.4% | -9.64% | 158% |
| Consumer Discretionary | XLY | -2.66% | 44.5% | -6.02% | 169% |
| Consumer Staples | XLP | 0.92% | 44.2% | -8.82% | 171% |
| Energy | XLE | 1.90% | 58.2% | 2.28% | 193% |
| Financial | XLF | -1.19% | 46.5% | -11.1% | 160% |
| Health Care | XLV | -2.50% | 48.1% | -1.82% | 181% |
| Industrial | XLI | -3.0% | 44.2% | -4.22% | 173% |
| Materials | XLB | -1.97% | 46.8% | 3.90% | 186% |
| Real Estate | XLRE | -1.06% | 45.7% | -2.62% | 164% |
| Technology | XLK | -5.03% | 42.7% | -0.17% | 175% |
| Utilities | XLU | 0.26% | 44.3% | -5.63% | 160% |
| Aerospace & Defense | XAR | -3.53% | 38.0% | -17.0% | 156% |
| Biotech | XBI | -3.88% | 42.1% | 9.13% | 184% |
| Homebuilder | XHB | -1.89% | 46.6% | 11.3% | 189% |
| Retail | XRT | -1.01% | 44.9% | 2.06% | 185% |